(Q83492293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

8

Sylwia Małgorzewicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

5

Zbigniew Heleniak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

4

Przemysław Rutkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

9

Bolesław Rutkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

3

Marcin Renke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1

Sławomir Lizakowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Maja Sławińska-Morawska

series ordinal

6

object named as

Maja Sławińska-Morawska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ewa Aleksandrowicz-Wrona

series ordinal

7

object named as

Ewa Aleksandrowicz-Wrona

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

23 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Hypertension

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

636-639

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Renin/prorenin receptors

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Transforming growth factor beta contributes to progressive diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Chronic kidney disease progression.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

TGF-beta in renal injury and disease

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

The increase in renin during renin inhibition: does it result in harmful effects by the (pro)renin receptor?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

PLZF and the (pro)renin receptor

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.14

7 January 2021

Identifiers

DOI

10.1038/AJH.2012.14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357413%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference